Yazar "Leiva-Fernandez, Francisca" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim
    Öğe
    Barriers and unmet educational needs regarding implementation of medication adherence management across Europe: insights from cost action enable
    (2024) Hafez, Gaye; Aarnio, Emma; Mucherino, Sara; Kamusheva, Maria; Qvarnström, Miriam; Potocnjak, Ines; Treciokiene, Indre; Mihajlovic, Jovan; Ekenberg, Marie; Boven, Job F. M. van; Leiva-Fernandez, Francisca; European Network to Advance Best Practices Technology on Medication AdherencE (ENABLE)
    Background: Medication adherence is essential for the achievement of therapeutic goals. Yet, the World Health Organization estimates that 50% of patients are nonadherent to medication and this has been associated with 125 billion euros and 200,000 deaths in Europe annually. Objective: This study aimed to unravel barriers and unmet training needs regarding medication adherence management across Europe. Design: A cross-sectional study was conducted through an online survey. The final survey contained 19 close-ended questions. Participants: The survey content was informed by 140 global medication adherence experts from clinical, academic, governmental, and patient associations. The final survey targeted healthcare professionals (HCPs) across 39 European countries. Main measures: Our measures were barriers and unmet training needs for the management of medication adherence across Europe. Key results: In total, 2875 HCPs (pharmacists, 40%; physicians, 37%; nurses, 17%) from 37 countries participated. The largest barriers to adequate medication adherence management were lack of patient awareness (66%), lack of HCP time (44%), lack of electronic solutions (e.g., access to integrated databases and uniformity of data available) (42%), and lack of collaboration and communication between HCPs (41%). Almost all HCPs pointed out the need for educational training on medication adherence management. Conclusions: These findings highlight the importance of addressing medication adherence barriers at different levels, from patient awareness to health system technology and to fostering collaboration between HCPs. To optimize patient and economic outcomes from prescribed medication, prerequisites include adequate HCP training as well as further development of digital solutions and shared health data infrastructures across Europe.
  • [ X ]
    Öğe
    Management of medication adherence across ENABLE COST countries: a pilot study
    (Springer, 2022) Mucherino, Sara; Aarnio, Emma; Hafez, Gaye; Kamusheva, Maria; Leiva-Fernandez, Francisca; Mihajlovic, Jovan; Qvarnstrom, Miriam
    [No abstract available]
  • Küçük Resim
    Öğe
    Pan-European survey on medication adherence management by healthcare professionals
    (2024) Kamusheva, Maria; Aarnio, Emma; Qvarnström, Miriam; Hafez, Gaye; Mucherino, Sara; Potocnjak, Ines; Treciokiene, Indre; Mihajlovic, Jovan; Ekenberg, Marie; Boven, Job F. M. van; Leiva-Fernandez, Francisca; European Network to Advance Best Practices and Technology on Medication AdherencE (ENABLE)
    Aims: While medication adherence (MA) is a key prerequisite for achieving optimal clinical and economic outcomes, nonadherence is highly prevalent. Assessing how healthcare professionals (HCPs) in Europe manage MA, focusing on measurement, reporting and interventions, is the subject of this study. Methods: A cross-sectional study was conducted among 40 European countries and quantitative analysis was conducted via an online survey. The multi-language online survey was created using Webropol 3.0 survey and reporting tool. Descriptive statistics and chi-squared tests were applied. Results: In total, 2875 HCPs (pharmacists: 39.9%; physicians: 36.7%; nurses: 16.4%) from 37 European countries participated. The most used methods for MA assessment were direct communication with patients (86.4%) and referring to personal patient records (56.7%) (P < 0.0001). Physicians (74.9%) and nurses (58.8%) were more aware of problems related to MA in contrast to pharmacists (48.6%) (P < 0.001). Almost all HCPs (92.6%) indicated that MA-enhancing interventions involved mainly direct communication with nonadherent patients (93.3%) and their caregivers (55.7%). Medication review and related optimization of therapy were mainly performed in Western European countries (46.8%). Technological solutions were ranked as one of the less applied approaches (10-15%) (P < 0.001). Conclusions: HCPs in all European regions recognize MA management as an integral element of overall patient-centred care. More efforts are needed to ensure timely, adequate and relevant MA assessment, reporting and improvement and involvement of all HCPs, especially among pharmacists who were generally less aware of MA issues. Promotion and use of digital technological solutions should be the focus of current and future clinical practice to optimize MA management processes.